8 hours ago Feb 06, 2017 . PACT application is a state of the art, comprehensive and scientifically validated in-clinic support tool for oncologists to assists them in their treatment decisions making. It is a reliable, effective and interactive ready reckoner/handbook on oncology. It helps the medical professionals in the ca…
Show more
See More
10 hours ago Dr. Reddy’s Laboratories - Multinational Pharmaceutical Company. Joining forces to fight COVID-19. We have brought in some of the most effective COVID-19 therapeutics to India via global partnerships to help patients through the pandemic. Good Health Can’t Wait. Know More. Latest updates. Stay up-to-date on all the developments to help ...
Show more
See More
7 hours ago Dr. Reddy's inks pact with Singapore firm to commercialise Trastuzumab biosimilar in select countries Prestige BioPharma Ltd, a Singapore-based firm and Dr. Reddys Laboratories Ltd., on Thursday announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and commercialization of the formers …
Show more
See More
10 hours ago mydrreddys Portal
Show more
See More
1 hours ago Dr Reddy's administers first dose of Sputnik V vaccine, imported doses at RS 995/jab. Click Here for the Complete Story [PDF Format] Dr Reddy's is not as big in India as it should be. We want to grow more. Click Here for the Complete Story [PDF Format]
Show more
See More
9 hours ago The Family PACT bulletin posted to the Medi-Cal website on April 16, 2021 announced effective May 3, 2021, the Health Access Programs (HAP) client enrollment system for the Family Planning, Access, Care and Treatment (Family PACT) Program will be updated. As a result, the Family PACT Client Eligibility Certification (CEC) form (DHCS 4461) and ...
Show more
See More
10 hours ago We would like to show you a description here but the site won’t allow us.
Show more
See More
4 hours ago Dr. Reddy’s inks pact with Singapore firm to commercialise Trastuzumab biosimilar in select countries. Hyderabad, Dec 9 (PTI): Prestige BioPharma Ltd, a Singapore-based firm and Dr. Reddy’s Laboratories Ltd., on Thursday announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and …
Show more
See More
8 hours ago Medi-Cal: Login to Medi-Cal. Home. Transaction Services. WARNING: This computer system is for official use by authorized users and may be monitored and/or restricted at any time. Confidential information may not be accessed or used without authorization. Unauthorized or improper use of this system may result in administrative discipline, civil ...
Show more
See More
4 hours ago Prestige BioPharma Ltd, a Singapore-based firm and Dr. Reddy’s Laboratories Ltd., on Thursday announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and commercialisation of the former’s proposed Trastuzumab biosimilar in select countries in Latin America and Southeast Asia. Prestige …
Show more
See More
2 hours ago Dr. Reddy's inks pact with Singapore firm to commercialise Trastuzumab biosimilar in select countries Hyderabad, Dec 9 PTI Prestige BioPharma Ltd, a Singapore-based firm and Dr. Reddys Laboratories Ltd., on Thursday announced that the two companies have entered into a binding agreement for an exclusive partnership for the supply and …
Show more
See More
1 hours ago Jun 06, 2012 . It further strengthens Merck Serono's promise to live science and transform lives, by increasing access to quality medicines for patients, physicians and payers." The deal structure calls for Merck Serono and Dr. Reddy's to co-develop the molecules included in the agreement.
Show more
See More
11 hours ago Aug 21, 2009 . In June, Dr Reddy's entered into a pact with GlaxoSmithKline GSK.L under which Glaxo will get access to its drugs and supply them in emerging markets such as Africa, the Middle East, and Latin ...
Show more
See More
5 hours ago The pact will allow these companies to manufacture remdesivir for distribution in 127 countries, which consist of nearly all low-income and lower-middle-income countries, as …
Show more
See More
4 hours ago Objective: To assess the availability of long acting reversible contraceptive (LARC) methods in Los Angeles County through providers participating in a California State Medicaid State Plan Amendment Program called Family Planning, Access, Care and Treatment (Family PACT). Study design: This was a cross-sectional telephone survey utilizing "secret shopper" methodology.
Show more
See More
The Family PACT Program covers the diagnosis and treatment of specified STIs for Family PACT clients as clinically indicated, when care is provided coincident, or pursuant, to a family planning service in a family planning setting.
Family PACT serves 1.1 million income eligible Californians of childbearing age through a network of 2,200 public and private providers. Services include comprehensive education, assistance, and services relating to family planning.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
The Family PACT bulletin posted to the Medi-Cal website on April 16, 2021 announced effective May 3, 2021, the Health Access Programs (HAP) client enrollment system for the Family Planning, Access, Care and Treatment (Family PACT) Program will be updated.